VAERS reports by lot

GSK Hepatitis A lot 337TC: VAERS reports

24 VAERS reports list lot 337TC as a GSK Hepatitis A vaccine, received between 2022-08-09 and 2024-08-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological822%
Dermatological (non-injection-site)822%
Injection-site / Local reaction617%
General / Systemic (non-local)514%
Allergic / Anaphylactic38%
Cardiac / Cardiovascular26%
Respiratory26%
Gastrointestinal13%
Musculoskeletal13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
Washington2
Connecticut2
Florida1
Georgia1
New Mexico1
Puerto Rico1
Iowa1
West Virginia1
Ohio1
Minnesota1
Kansas1

Reports by month received

2022-083
2022-096
2022-101
2022-122
2023-014
2023-042
2023-061
2023-071
2023-121
2024-062
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.